<DOC>
	<DOC>NCT01262794</DOC>
	<brief_summary>To evaluate the safety and tolerability of CDP6038 following single dose subcutaneous (sc) administration of CDP6038 to Japanese subjects. To evaluate the Pharmacokinetics of CDP6038 following single dose sc administration of CDP6038 to Japanese subjects</brief_summary>
	<brief_title>Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy Japanese volunteers Subject has participated in any other clinical drug study (including a biologic product or a medical device) within 5 PK halflives or 3 months (whichever is longer) prior to Screening, or the subject is currently participating in another clinical study. Subject is not healthy (eg, taking any drug treatments, any psychological or emotional problems, a drug/alcohol abuse or a having a history of drug/alcohol abuse, having abnormal safety parameters)</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Healthy volunteers</keyword>
	<keyword>Japanese</keyword>
</DOC>